These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33415165)

  • 1. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Huang X; Xiong Y; Yang J; Yang G; Li J
    Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
    Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miR-522 is associated with poor outcome of hepatocellular carcinoma.
    Shi YH; Qi BB; Liu XB; Ding HM
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3194-8. PubMed ID: 27466991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
    Gu H; Guo X; Zou L; Zhu H; Zhang J
    Mol Cell Biochem; 2013 Mar; 375(1-2):23-30. PubMed ID: 23291979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
    Zhang Y; Li Y; Jiang W; Li Q; Lan Y
    Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.
    Su ZX; Zhao J; Rong ZH; Geng WM; Wu YG; Qin CK
    Diagn Pathol; 2014 Mar; 9():47. PubMed ID: 24593846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Wang X; Huang Y; Zhuang H; Qian Y; Zhao Q; Yang L; Gu H; Chen J; Guo R; Liu Y
    Clin Lab; 2015; 61(9):1331-6. PubMed ID: 26554254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.
    Li B; Huang P; Qiu J; Liao Y; Hong J; Yuan Y
    Med Oncol; 2014 Oct; 31(10):230. PubMed ID: 25218269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
    Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
    Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
    Chen L; Jiang M; Yuan W; Tang H
    J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma.
    Zhou L; Qu YM; Zhao XM; Yue ZD
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):825-9. PubMed ID: 27010136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
    Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y
    Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.